James P. Allison and Tasuku Honjo were recognized for a discovery that the body’s immune system can be used to attack cancer cells.
Breaking News: The Nobel Prize in Medicine recognized breakthroughs in using the immune system to attack cancer. It went to James P. Allison and Tasuku Honjo. https://t.co/vnWpRGRebt
— The New York Times (@nytimes) 1 octobre 2018
Patrick Nef, CEO of TransCure bioServices reacts to Jim Allison and Tasuku Honjo’s awards for their research on immunotherapy:
“It’s a very good news for the scientific world and for the patients! We are proud to be part of this revolution. Since the first results published by James P. Allison and Tasuku Honjo, many of our customers have been involved in this immuno-oncology field. Indeed, our fully functional human immune system humanized mouse model is the preferred in vivo model for testing combination strategy”